↑ Breaking News: Business 'Stranger Things' ushered in a new era for Netflix - A lot has changed since its first season in 2016, as Netflix has announced dozens of "Stranger Things" partnerships and collaborations with brands.Homeowners are losing thousands in equity thanks to weakening prices - Weaker prices mean homeowners are starting to lose equity after several years of huge gains.‘The next protein’: Fiber is shaping up to be the latest grocery obsession - As consumers find their next grocery obsession in fiber, food and beverage companies are racing to keep up with the trend.AI shopping could drive $263 billion in holiday sales. Walmart and Target are racing to get in - Consumers are turning to AI chatbots like ChatGPT for gift discovery, reviews and price matching, potentially driving billions in sales this holiday season.Lululemon CEO Calvin McDonald to depart in January as retailer struggles to compete, woo shoppers - Lululemon's CEO Calvin McDonald will leave the athleisure retailer at the end of January as sales in its largest market sag and consumers flee to competitors.Costco tops Wall Street's sales and revenue expectations - Costco on Thursday surpassed Wall Street's quarterly expectations as its sales rose 8.2% year over year.Home prices go negative for the first time in over 2 years — and may stay that way for a while - Home prices have not gone negative since mid-2023, a year after the Federal Reserve first brought rates up from zero, and mortgage rates moved sharply higher.Rivian announces new AI tech, in-house chip and robotaxi ambitions - The company has also developed AI models to power its Autonomy+ subscription, which it intends to roll out early next year for $2,500 upfront or $49.99 a month.Disney making $1 billion investment in OpenAI, will allow characters on Sora AI video generator - TechDisney making $1 billion investment in OpenAI, will allow characters on Sora AI video generatorPublished Thu, Dec 11 20259:02 AM ESTUpdated 4 Min AgoAshley Eli Lilly's next-generation obesity drug delivers strong weight loss, reduces knee pain in late-stage trial - The drugmaker is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection Zepbound and its upcoming pill.